Amneal Pharmaceuticals
AMRX
AMRX
127 hedge funds and large institutions have $342M invested in Amneal Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
8.65% less ownership
Funds ownership: 75.43% → 66.78% (-8.7%)
30% less capital invested
Capital invested by funds: $488M → $342M (-$145M)
47% less call options, than puts
Call options by funds: $305K | Put options by funds: $574K
Holders
127
Holding in Top 10
1
Calls
$305K
Puts
$574K
Top Buyers
| 1 | +$3.65M | |
| 2 | +$1.94M | |
| 3 | +$1.08M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$862K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$755K |
Top Sellers
| 1 | -$8.29M | |
| 2 | -$3.78M | |
| 3 | -$2.94M | |
| 4 |
Two Sigma Investments
New York
|
-$2.56M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$1.45M |